Početna › Difuzni veliki B-stanični limfom › Virginia › Richmond
Kliničke studije za Difuzni veliki B-stanični limfom u gradu Richmond, VA
10 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Richmond i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
U tijeku regrutacijaFaza 2
- VCU Massey Comprehensive Cancer Center, Richmond
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
U tijeku regrutacijaFaza 1/2
- Virginia Commonwealth University Massey Cancer Center, Richmond
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
U tijeku regrutacijaFaza 3
- Virginia Cancer Institute ( Site 0148), Richmond
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
U tijeku regrutacijaFaza 2
- VCU Health Adult Outpatient Pavillion ( Site 0138), Richmond
A Study of ARC-02 in B-cell NHL
U tijeku regrutacijaFaza 1
- Massey Cancer Center, Richmond
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- Virginia Commonwealth University-Massey Cancer Center, Richmond
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1/2
- VCU Massey Comprehensive Cancer Center, Richmond
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
U tijeku regrutacijaFaza 2
- VCU Massey Comprehensive Cancer Center, Richmond
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
U tijeku regrutacijaFaza 2
- Virginia Commonwealth University, Richmond
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
U tijeku regrutacijaFaza 2
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Studije za Difuzni veliki B-stanični limfom u drugim gradovima
- New York City, NY21 studija
- Baldwin Park, CA19 studija
- Chicago, IL18 studija
- Houston, TX17 studija
- Los Angeles, CA17 studija
- Boston, MA16 studija
- Milwaukee, WI16 studija
- Nashville, TN15 studija
- Portland, OR15 studija
- Philadelphia, PA15 studija
- Durham, NC14 studija
- Dallas, TX13 studija
Ostale studije u gradu Richmond
- Rak dojke26 studija
- Nemikrocelularni karcinom pluća25 studija
- Rak prostate19 studija
- Srčano zatajenje16 studija
- Rak pluća14 studija
- Kolorektalni rak13 studija
- Kardiovaskularne bolesti13 studija
- Steatoza jetre12 studija
- Akutna mijeloična leukemija12 studija
- Pločastostanični karcinom glave i vrata12 studija
- Metastatski karcinom12 studija
- Melanom11 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.